In addition, TF3 dietary intervention can also significantly up-regulate the gene expression of AMPK α, a key regulator of glucose and lipid metabolism, and down-regulate the expression of the SREBP1c gene to inhibit the synthesis of triglycerides and cholesterol in T2DM mice. The gene discussed is SREBF1; the disease is type 2 diabetes mellitus.